首页> 外文期刊>Genetic Testing >RNA Analysis of Consensus Sequence Splicing Mutations: Implications for the Diagnosis of Wilson Disease
【24h】

RNA Analysis of Consensus Sequence Splicing Mutations: Implications for the Diagnosis of Wilson Disease

机译:共有序列剪接突变的RNA分析:对威尔逊病的诊断意义。

获取原文
获取原文并翻译 | 示例
       

摘要

Wilson disease (WD) is an autosomal recessive disorder caused by a defective function of the copper-transporting ATP7B protein. This results in progressive copper overload and consequent liver, brain, and kidney damage. Approximately 300 WD-causing mutations have been described to date. Missense mutations are largely prevalent, while splice-site mutations are rarer. Of these, only a minority are detected in splicing consensus sequences. Further, few splicing mutations have been studied at the RNA level. In this study we report the RNA molecular characterization of three consensus splice-site mutations identified by DNA analysis in WD patients. One of them, c.51 + 4 A → T, resides in the consensus sequence of the donor splice site of intron 1; the second, c. 2121 + 3 A → G, occurred in position + 3 of intron 7; and the c.2447 + 5 G → A is localized in the consensus sequence of the donor splice site of intron 9. Analysis revealed predominantly abnormal splicing in the samples carrying mutations compared to the normal controls. These results strongly suggest that consensus sequence splice-site mutations result in disease by interfering with the production of the normal WD protein. Our data contribute to understanding the mutational spectrum that affect splicing and improve our capability in WD diagnosis.
机译:威尔逊病(WD)是一种常染色体隐性遗传疾病,由铜转运ATP7B蛋白的功能缺陷引起。这导致进行性铜超负荷,继而对肝,脑和肾造成损害。迄今为止已经描述了约300种引起WD的突变。错义突变在很大程度上很普遍,而剪接位点突变则很少见。其中,在剪接共有序列中仅检测到少数。另外,在RNA水平上很少研究剪接突变。在这项研究中,我们报告了通过WD患者的DNA分析鉴定的三个共有剪接位点突变的RNA分子特征。其中一个,c.51 + 4 A→T,位于内含子1供体剪接位点的共有序列中。第二个,c。 2121 + 3 A→G,出现在内含子7的+3位置;并且c.2447 + 5 G→A位于内含子9供体剪接位点的共有序列中。与正常对照相比,分析显示携带突变的样品中主要是异常剪接。这些结果有力地表明,共有序列剪接位点突变通过干扰正常WD蛋白的产生而导致疾病。我们的数据有助于理解影响剪接的突变谱并提高我们在WD诊断中的能力。

著录项

  • 来源
    《Genetic Testing》 |2009年第2期|185-191|共7页
  • 作者单位

    Istituto di Neurogenetica e Neurofarmacologia, CNR, Cagliari, Italy;

    Dipartimento di Scienze Biomediche e Biotecnologie, USC, Cagliari, Italy;

    Dipartimento di Scienze Biomediche e Biotecnologie, USC, Cagliari, Italy;

    Dipartimento di Scienze Biomediche e Biotecnologie, USC, Cagliari, Italy;

    Dipartimento di Scienze Biomediche e Biotecnologie, USC, Cagliari, Italy;

    Dipartimento di Pediatria, Universita Federico II, Naples, Italy;

    Dipartimento di Pediatria, Universita Federico II, Naples, Italy;

    Dipartimento di Scienze Neurologiche, Universita Federico II, Naples, Italy;

    Dipartimento di Scienze Neurologiche, Universita Federico II, Naples, Italy;

    Dipartimento di Medicina della Procreazione e dell'Eta Evolutiva, Pisa, Italy;

    Dipartimento di Scienze Biomediche e Biotecnologie, USC, Cagliari, Italy;

    Istituto di Neurogenetica e Neurofarmacologia, CNR, Cagliari, Italy;

    Ospedale Regionale per le Microcitemie, Cagliari, Italy Ospedale Regionale Microcitemie ASL 8, Cagliari Via Jenner s 09121 Cagliari Italy;

  • 收录信息 美国《科学引文索引》(SCI);美国《化学文摘》(CA);
  • 原文格式 PDF
  • 正文语种 eng
  • 中图分类
  • 关键词

  • 入库时间 2022-08-17 13:21:27

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号